相关实验视频

Updated: Jul 3, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

与MASLD/MASH相关的HCC中的分子机制

Xiaobo Wang¹, Liang Zhang², Bingning Dong²

¹Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.

Hepatology (Baltimore, Md.)

|February 13, 2024

概括

代谢功能障碍相关的脂肪肝炎 (MASH) 可能导致MASH相关的肝癌 (MASH-HCC). 了解MASH-HCC分子机制是开发更好的治疗方法和改善这种日益严重的全球健康问题的患者结果的关键.

科学领域:

肝病学肝病学是一种肝病学.
在瘤学瘤学.
代谢疾病代谢疾病

背景情况:

肝癌是全球主要的健康问题,在患病率上排名第六,癌症死亡人数排名第三.
代谢功能障碍相关的脂肪性肝病 (NAFLD) 和其严重形式,代谢功能障碍相关的脂肪性肝炎 (MASH),影响20-25%的人口.
随着肥胖和代谢性疾病 (如2型糖尿病,胰岛素抵抗和脂肪肝) 的增加,MASH的患病率正在上升.

研究的目的:

提供有关MASH相关肝细胞癌 (MASH-HCC) 的当前研究的全面审查.
巩固现有发现,并介绍最新的MASH-HCC分子过程的见解.
探索改善治疗策略和患者治疗结果的途径.

主要方法:

关于MASH-HCC. 的综合文献综述.
对分子机制,遗传变异和体质突变的分析.
检查疾病进展模型,多组学数据和免疫学因素.

主要成果:

与其他HCC类型相比,MASH-HCC具有独特的分子和免疫特征.
每年进展到MASH-HCC发生在大约2%的MASH病例中.
目前的治疗包括手术,局部治疗和全身治疗,如抗血管生成疗法和免疫检查点抑制剂.

结论:

进一步了解MASH-HCC分子机制对于推进治疗策略至关重要.
识别治疗反应的生物标志物对于个性化医学至关重要.
增强理解旨在催化更强效疗法的开发,以改善患者的治疗结果.

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...